![Alan Montgomery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Montgomery
Directeur/Membre du Conseil chez
XENCOR, INC.
Fortune : 184 698 $ au 31/05/2026
Profil
Alan Bruce Montgomery was the founder of Corus Pharma, Inc., founded in 2001, where the title held was Chief Executive Officer from 2001 to 2008.
Dr. Montgomery was the founder of Cardeas Pharma Corp., founded in 2010, where the title held was Chief Executive Officer & Director from 2012 to 2016.
Current jobs include Lead Independent Director at Xencor, Inc. since 2015, Director at Vicis LLC, and Investment Committee Member at W Fund Management LLC.
Former jobs include Chief Executive Officer & Director at Avalyn Pharma, Inc. from 2017 to 2022; Director at ZymoGenetics, Inc. in 2010; Independent Director at CytoDyn, Inc. from 2014 to 2018; Director at Geospiza, Inc.; Director at LeonaBio, Inc.; Director at Light Sciences Corp.; Director at Life Science Washington; Independent Director at Lundbeck Seattle BioPharmaceuticals, Inc. from 2014 to 2019; Director at Pacific Science Center; Senior Vice President-Respiratory Therapeutics at Gilead Sciences, Inc. from 2006 to 2011; Executive Vice President-Research & Development at PathoGenesis Corp from 1993 to 2000; Trustee-Washington State at Life Sciences Discovery Fund.
Education includes undergraduate and doctorate degrees from the University of Washington.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XENCOR, INC. 0,02% | 15/06/2026 | 15 547 ( 0,02% ) | 184 698 $ | 31/05/2026 |
Postes actifs de Alan Montgomery
| Sociétés | Poste | Début |
|---|---|---|
| XENCOR, INC. | Directeur/Membre du Conseil | 18/03/2015 |
W Fund Management LLC
 W Fund Management LLC Investment ManagersFinance W Fund invests in companies located in the United States. The firm focuses on science, software, information technology, engineering and clean technology sectors with an investment size of USD 0.5 - 1 million. It participates in seed and early stage transactions. | Membre du Comité d'Investissement | - |
Vicis LLC
 Vicis LLC Recreational ProductsConsumer Durables Develops football helmets | Directeur/Membre du Conseil | - |
Anciens postes connus de Alan Montgomery
| Sociétés | Poste | Fin |
|---|---|---|
| AVALYN PHARMA INC. | Directeur Général | 14/10/2022 |
| ALDER BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2019 |
| CYTODYN INC. | Directeur/Membre du Conseil | 11/07/2018 |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Provides drugs for the prevention of ventilator associated pneumonia | Fondateur | 01/01/2016 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/05/2011 |
Formation de Alan Montgomery
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases | Health Technology |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas | Health Technology |
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
Geospiza, Inc.
 Geospiza, Inc. Packaged SoftwareTechnology Services Develops enterprise-class software systems for workflow management of genetic analysis | Technology Services |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Cardeas Pharma Corp.
Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Provides drugs for the prevention of ventilator associated pneumonia | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Light Sciences Corp.
 Light Sciences Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals and biotherapeutics products | Health Technology |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Pacific Science Center
 Pacific Science Center Other Consumer ServicesConsumer Services Operates as a science museum | Consumer Services |
Life Sciences Discovery Fund
 Life Sciences Discovery Fund Miscellaneous Commercial ServicesCommercial Services Promotes life sciences competitiveness and enhance economic vitality | Commercial Services |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund invests in companies located in the United States. The firm focuses on science, software, information technology, engineering and clean technology sectors with an investment size of USD 0.5 - 1 million. It participates in seed and early stage transactions. | Finance |
Vicis LLC
Vicis LLC Recreational ProductsConsumer Durables Develops football helmets | Consumer Durables |
